Salt Lake City-based Predictive Technology Group's Predictive Biotech beta launched its molecular diagnostic test for spinal deformities, according to Digital Journal.
Here are four key points:
1. The diagnostic test is designed to predict spine deformity and syndrome severity.
2. The test will initially focus on scoliosis.
3. Predictive Biotech is awaiting patent approval of the technology.
4. The company plans to collaborate with spine societies to enhance the technology to meet surgeons' clinical needs.